| For: | Kumar M, Liu ZR, Thapa L, Chang Q, Wang DY, Qin RY. Antiangiogenic effect of somatostatin receptor subtype 2 on pancreatic cancer cell line: Inhibition of vascular endothelial growth factor and matrix metalloproteinase-2 expression in vitro. World J Gastroenterol 2004; 10(3): 393-399 [PMID: 14760765 DOI: 10.3748/wjg.v10.i3.393] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i3/393.htm |
| Number | Citing Articles |
| 1 |
G. Bocci, M. D. Culler, A. Fioravanti, P. Orlandi, A. Fasciani, R. Colucci, J. E. Taylor, D. Sadat, R. Danesi, M. Del Tacca. In vitro antiangiogenic activity of selective somatostatin subtype‐1 receptor agonists. European Journal of Clinical Investigation 2007; 37(9) doi: 10.1111/j.1365-2362.2007.01848.x
|
| 2 |
Hui-Feng Hao, Li-Mei Liu, Yu-Ying Liu, Juan Liu, Li Yan, Chun-Shui Pan, Ming-Xia Wang, Chuan-She Wang, Jing-Yu Fan, Yuan-Sheng Gao, Jing-Yan Han. Inhibitory effect of rhynchophylline on contraction of cerebral arterioles to endothelin 1: Role of rho kinase. Journal of Ethnopharmacology 2014; 155(1) doi: 10.1016/j.jep.2014.04.050
|
| 3 |
Xiaoqi Zhou, Chenyu Song, Lujie Li, Yangdi Wang, Zhoulei Li, Shi-Ting Feng, Yanji Luo, Zhenpeng Peng. CT-based nomogram development and validation to predict SSTR2, VEGFR2 and MGMT expression for pancreatic neuroendocrine neoplasms. Chinese Journal of Academic Radiology 2023; 6(3) doi: 10.1007/s42058-023-00124-x
|
| 4 |
C. Susini, L. Buscail. Rationale for the use of somatostatin analogs as antitumor agents. Annals of Oncology 2006; 17(12) doi: 10.1093/annonc/mdl105
|
| 5 |
Nicolas Carrere, Fabienne Vernejoul, Anny Souque, Amani Asnacios, Nicole Vaysse, Lucien Pradayrol, Christiane Susini, Louis Buscail, Pierre Cordelier. Characterization of the Bystander Effect of Somatostatin Receptor sst2 After In Vivo Gene Transfer into Human Pancreatic Cancer Cells. Human Gene Therapy 2005; 0(0) doi: 10.1089/hum.2005.16.ft-120
|
| 6 |
I. M. MODLIN, M. PAVEL, M. KIDD, B. I. GUSTAFSSON. Review article: somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine (carcinoid) tumours. Alimentary Pharmacology & Therapeutics 2010; 31(2) doi: 10.1111/j.1365-2036.2009.04174.x
|
| 7 |
Agnieszka Milewska-Kranc, Jarosław B. Ćwikła, Agnieszka Kolasinska-Ćwikła. The Role of Receptor–Ligand Interaction in Somatostatin Signaling Pathways: Implications for Neuroendocrine Tumors. Cancers 2023; 16(1) doi: 10.3390/cancers16010116
|
| 8 |
M. Annunziata, R. M. Luque, M. Duran-Prado, A. Baragli, C. Grande, M. Volante, M. D. Gahete, F. Deltetto, M. Camanni, E. Ghigo, J. P. Castano, R. Granata. Somatostatin and somatostatin analogues reduce PDGF-induced endometrial cell proliferation and motility. Human Reproduction 2012; 27(7) doi: 10.1093/humrep/des144
|
| 9 |
Haliza Haniff, Robert D. Murray. Growth Hormone Related Diseases and Therapy. 2011; doi: 10.1007/978-1-60761-317-6_14
|
| 10 |
Nicolas Carrere, Fabienne Vernejoul, Anny Souque, Amani Asnacios, Nicole Vaysse, Lucien Pradayrol, Christiane Susini, Louis Buscail, Pierre Cordelier. Characterization of the Bystander Effect of Somatostatin Receptor sst2 AfterIn VivoGene Transfer into Human Pancreatic Cancer Cells. Human Gene Therapy 2005; 16(10) doi: 10.1089/hum.2005.16.1175
|
| 11 |
Bernadette V. Marquez, Oluwatayo F. Ikotun, Jesse J. Parry, Buck E. Rogers, Claude F. Meares, Suzanne E. Lapi. Development of a Radiolabeled Irreversible Peptide Ligand for PET Imaging of Vascular Endothelial Growth Factor. Journal of Nuclear Medicine 2014; 55(6) doi: 10.2967/jnumed.113.130898
|
| 12 |
Jonathan R. Strosberg, Asima Cheema, Larry K. Kvols. A Review of Systemic and Liver-Directed Therapies for Metastatic Neuroendocrine Tumors of the Gastroenteropancreatic Tract. Cancer Control 2011; 18(2) doi: 10.1177/107327481101800207
|
| 13 |
M. Kilian, J. I. Gregor, I. Heukamp, K. Helmecke, M. Hanel, B. Wassersleben, M. K. Walz, I. Schimke, G. Kristiansen, F. A. Wenger. Impact of Octreotide and SOM-230 on liver metastasis and hepatic lipidperoxidation in ductal pancreatic adenocarcinoma in Syrian Hamster. Clinical & Experimental Metastasis 2009; 26(7) doi: 10.1007/s10585-009-9271-x
|
| 14 |
Si-Xue Liu, Zhong-Sheng Xia, Ying-Qiang Zhong. Gene therapy in pancreatic cancer. World Journal of Gastroenterology 2014; 20(37): 13343-13368 doi: 10.3748/wjg.v20.i37.13343
|
| 15 |
Yulin Song, Qixin Zheng, Yongchao Wu, Xiaodong Guo. Two-dimensional effects of hydrogel self-organized from IKVAV-containing peptides on growth and differentiation of NSCs. Journal of Wuhan University of Technology-Mater. Sci. Ed. 2009; 24(2) doi: 10.1007/s11595-009-2186-1
|
| 16 |
Fei Liu, Hua Zhu, Chuangui Li, Xinfeng Lin, Chiyi Xiong, Chun Li, Zhi Yang. Design and radio-synthesis of somatostatin receptors targeted 68Ga-DOTA-Benereotide for non-invasive PET imaging. Journal of Radioanalytical and Nuclear Chemistry 2016; 307(2) doi: 10.1007/s10967-015-4241-z
|
| 17 |
Federico Gatto, Federica Barbieri, Marica Arvigo, Stefano Thellung, Jessica Amarù, Manuela Albertelli, Diego Ferone, Tullio Florio. Biological and Biochemical Basis of the Differential Efficacy of First and Second Generation Somatostatin Receptor Ligands in Neuroendocrine Neoplasms. International Journal of Molecular Sciences 2019; 20(16) doi: 10.3390/ijms20163940
|
| 18 |
Reuven Reich, Yiffat Katz, Rivka Hadar, Eli Breuer. Carbamoylphosphonate Matrix Metalloproteinase Inhibitors 3: In vivo Evaluation of Cyclopentylcarbamoylphosphonic Acid in Experimental Metastasis and Angiogenesis. Clinical Cancer Research 2005; 11(10) doi: 10.1158/1078-0432.CCR-04-1985
|
| 19 |
Manuel D. Gahete, David Rincón-Fernández, Mario Durán-Prado, Marta Hergueta-Redondo, Alejandro Ibáñez-Costa, Alejandro Rojo-Sebastián, Francisco Gracia-Navarro, Michael D. Culler, Oriol Casanovas, Gema Moreno-Bueno, Raúl M. Luque, Justo P. Castaño. The truncated somatostatin receptor sst5TMD4 stimulates the angiogenic process and is associated to lymphatic metastasis and disease-free survival in breast cancer patients. Oncotarget 2016; 7(37) doi: 10.18632/oncotarget.11076
|
| 20 |
. 2009; doi: 10.70675/05d459bfzfd2dz4abbzbe1dz1b9ab1534fc9
|
| 21 |
. 2010; doi: 10.70675/4ec96bb8ze1a3z4f7dz95eaz0aa9688f9b2b
|
| 22 |
|
| 23 |
Panagiotis J. Vlachostergios, Ioannis A. Voutsadakis, Christos N. Papandreou. The shaping of invasive glioma phenotype by the ubiquitin–proteasome system. Cell Communication & Adhesion 2013; 20(5) doi: 10.3109/15419061.2013.833192
|
| 24 |
Shaoyu Yan, Min Li, Hong Chai, Hui Yang, Peter H. Lin, Qizhi Yao, Changyi Chen. TNF-α decreases expression of somatostatin, somatostatin receptors, and cortistatin in human coronary endothelial cells. Journal of Surgical Research 2005; 123(2) doi: 10.1016/j.jss.2004.07.244
|
| 25 |
Taymeyah Al-Toubah, Jonathan Strosberg. Neuroendocrine Tumours. 2024; doi: 10.1007/978-3-031-56968-5_30
|